Dexamethasone Sodium Phosphate/Lidocaine Hydrochloride
地塞米松磷酸钠/盐酸利多卡因
Report date: 2026/02/06 20:01:23
Base Information
Drug NameDexamethasone Sodium Phosphate/Lidocaine Hydrochloride
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1962/07/11
Country/Territory
CombinationsYes Dexamethasone Sodium PhosphateLidocaine Hydrochloride
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A
Develop Information
Active CompaniesInstitute Of Oncology Ljubljana
Inactive CompaniesMerck & Co Inc
Active Indications
Inactive Indications
Other Information
ATC Code
Related LinksN/A